Novo’s Weight Loss Drugs Removed from FDA Shortage List
The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...
Extra.ie on MSN3h
‘King Kong’ of weight loss drugs should be available for free in Ireland, expert says
The country’s foremost expert on obesity has urged the Health Service Executive to make the ‘King Kong’ of weight loss drugs ...
Is Eli Lilly and Company (LLY) the Top Stock to Buy According to Sustainable Insight Capital Management?
We recently published a list of Top 10 Stocks to Buy According to Sustainable Insight Capital Management. In this article, we ...
Eli Lilly's Breakout Is Nearly Here: Performance Metrics/Bullish Support Remain Robust
Eli Lilly's stock offers high growth potential, driven by GLP-1 therapies and strong R&D efforts. Read why LLY stock is ...
Eli Lilly and Company (NYSE:LLY) Stock Acquired Sen. Ron Wyden
Senator Ron Wyden (D-Oregon) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on February 21st, the Senator disclosed that they had bought between $50,001 and $100,000 ...
devdiscourse17h
Health Sector Shifts: From Drug Approvals to Supply Disruptions
The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...
Top 10 Stocks to Buy According to Sustainable Insight Capital Management
Sustainable Insight Capital Management (SICM) focuses on institutional investments, offering both long-only and long-short strategies in public equities.